AVTR vs LEN · P/E 13, rev $6.55B vs rev $34.19B
Avantor Inc (AVTR) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Avantor Inc (AVTR) is a medical instruments & supplies company listed on US.
LEN (LEN) common stock.
Latest reported AVTR revenue for 2025-12-31 was $6.55B. Net income was -$530.2M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
AVTR currently screens at market cap $9.36B and trailing P/E 13.3. LEN currently screens at market cap $0.
Not investment advice. Open the AVTR and LEN stock pages for the full models.
Not investment advice.